Astrana Health Inc (ASTH)
42.11
+1.07
(+2.61%)
USD |
NASDAQ |
Nov 21, 16:00
42.04
-0.07
(-0.17%)
After-Hours: 20:00
Astrana Health Enterprise Value: 1.813B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.813B |
| November 20, 2024 | 1.764B |
| November 19, 2024 | 1.759B |
| November 18, 2024 | 1.740B |
| November 15, 2024 | 1.753B |
| November 14, 2024 | 1.803B |
| November 13, 2024 | 1.804B |
| November 12, 2024 | 1.849B |
| November 11, 2024 | 2.027B |
| November 08, 2024 | 2.034B |
| November 07, 2024 | 2.588B |
| November 06, 2024 | 2.606B |
| November 05, 2024 | 2.566B |
| November 04, 2024 | 2.485B |
| November 01, 2024 | 2.496B |
| October 31, 2024 | 2.460B |
| October 30, 2024 | 2.547B |
| October 29, 2024 | 2.558B |
| October 28, 2024 | 2.570B |
| October 25, 2024 | 2.551B |
| October 24, 2024 | 2.549B |
| October 23, 2024 | 2.502B |
| October 22, 2024 | 2.657B |
| October 21, 2024 | 2.762B |
| October 18, 2024 | 2.785B |
| Date | Value |
|---|---|
| October 17, 2024 | 2.823B |
| October 16, 2024 | 2.878B |
| October 15, 2024 | 2.808B |
| October 14, 2024 | 2.740B |
| October 11, 2024 | 2.577B |
| October 10, 2024 | 2.613B |
| October 09, 2024 | 2.677B |
| October 08, 2024 | 2.706B |
| October 07, 2024 | 2.725B |
| October 04, 2024 | 2.752B |
| October 03, 2024 | 2.732B |
| October 02, 2024 | 2.655B |
| October 01, 2024 | 2.654B |
| September 30, 2024 | 2.659B |
| September 27, 2024 | 2.494B |
| September 26, 2024 | 2.478B |
| September 25, 2024 | 2.457B |
| September 24, 2024 | 2.450B |
| September 23, 2024 | 2.516B |
| September 20, 2024 | 2.515B |
| September 19, 2024 | 2.553B |
| September 18, 2024 | 2.522B |
| September 17, 2024 | 2.446B |
| September 16, 2024 | 2.429B |
| September 13, 2024 | 2.400B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
529.00M
Minimum
Mar 16 2020
5.276B
Maximum
Nov 16 2021
1.714B
Average
1.573B
Median
May 21 2021
Enterprise Value Benchmarks
| Evolent Health Inc | 1.836B |
| American Shared Hospital Services | 34.29M |
| Cryo-Cell International Inc | 75.52M |
| P3 Health Partners Inc | 248.89M |
| Biote Corp | 275.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 16.09M |
| Revenue (Quarterly) | 478.71M |
| Total Expenses (Quarterly) | 450.28M |
| EPS Diluted (Quarterly) | 0.33 |
| Gross Profit Margin (Quarterly) | 15.35% |
| Profit Margin (Quarterly) | 3.36% |
| Earnings Yield | 3.09% |
| Operating Earnings Yield | 4.21% |
| Normalized Earnings Yield | 3.021 |